3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to investigate whether the Menostar patch is as safe and effective
in the prevention of bone loss in postmenopausal women as raloxifen, a drug already
registered for prevention and treatment of osteoporosis.